JP2019524889A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524889A5 JP2019524889A5 JP2019530368A JP2019530368A JP2019524889A5 JP 2019524889 A5 JP2019524889 A5 JP 2019524889A5 JP 2019530368 A JP2019530368 A JP 2019530368A JP 2019530368 A JP2019530368 A JP 2019530368A JP 2019524889 A5 JP2019524889 A5 JP 2019524889A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- composition according
- effective amount
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims description 35
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000000651 prodrug Substances 0.000 claims description 10
- 229940002612 prodrug Drugs 0.000 claims description 10
- 150000003839 salts Chemical class 0.000 claims description 10
- 208000001132 Osteoporosis Diseases 0.000 claims description 4
- 210000001789 adipocyte Anatomy 0.000 claims description 4
- 210000000577 adipose tissue Anatomy 0.000 claims description 4
- 208000024891 symptom Diseases 0.000 claims description 4
- 102000011690 Adiponectin Human genes 0.000 claims description 3
- 108010076365 Adiponectin Proteins 0.000 claims description 3
- 206010065687 Bone loss Diseases 0.000 claims description 3
- 210000000963 osteoblast Anatomy 0.000 claims description 3
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical class [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 230000008468 bone growth Effects 0.000 claims description 2
- 230000003442 weekly effect Effects 0.000 claims description 2
- 230000002354 daily effect Effects 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 1
- 230000003203 everyday effect Effects 0.000 claims 1
- 230000001582 osteoblastic effect Effects 0.000 claims 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022090843A JP2022116294A (ja) | 2016-08-18 | 2022-06-03 | 骨疾患の治療のためのＰＰＡＲγアゴニスト |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662376732P | 2016-08-18 | 2016-08-18 | |
| US62/376,732 | 2016-08-18 | ||
| PCT/US2017/047584 WO2018035449A1 (en) | 2016-08-18 | 2017-08-18 | Pparϒ agonist for treatment of bone disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022090843A Division JP2022116294A (ja) | 2016-08-18 | 2022-06-03 | 骨疾患の治療のためのＰＰＡＲγアゴニスト |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019524889A JP2019524889A (ja) | 2019-09-05 |
| JP2019524889A5 true JP2019524889A5 (cg-RX-API-DMAC7.html) | 2020-10-01 |
Family
ID=61197122
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530368A Pending JP2019524889A (ja) | 2016-08-18 | 2017-08-18 | 骨疾患の治療のためのＰＰＡＲγアゴニスト |
| JP2022090843A Withdrawn JP2022116294A (ja) | 2016-08-18 | 2022-06-03 | 骨疾患の治療のためのＰＰＡＲγアゴニスト |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022090843A Withdrawn JP2022116294A (ja) | 2016-08-18 | 2022-06-03 | 骨疾患の治療のためのＰＰＡＲγアゴニスト |
Country Status (11)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220070057A (ko) | 2015-03-09 | 2022-05-27 | 인테크린 테라퓨틱스, 아이엔씨. | 비알코올성 지방간 질환 및/또는 지방이영양증의 치료 방법 |
| SG11201909046XA (en) | 2017-04-03 | 2019-10-30 | Coherus Biosciences Inc | PPARγ AGONIST FOR TREATMENT OF PROGRESSIVE SUPRANUCLEAR PALSY |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2407587A1 (en) * | 2000-04-28 | 2001-11-08 | Sankyo Company, Limited | Ppar.gamma. modulators |
| US7223761B2 (en) * | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
| CA2555914A1 (en) * | 2004-03-08 | 2005-09-22 | Amgen Inc. | Therapeutic modulation of ppar (gamma) activity |
| AU2014212740B2 (en) * | 2013-01-30 | 2015-12-24 | Intekrin Therapeutics, Inc. | PPARy agonists for treatment of multiple sclerosis |
| MY194308A (en) * | 2014-10-10 | 2022-11-27 | Prometic Pharma Smt Ltd | Substituted aromatic compounds and pharmaceutical compostions for the prevention and treatment of osteoporosis |
-
2017
- 2017-08-18 SG SG10202101500WA patent/SG10202101500WA/en unknown
- 2017-08-18 AU AU2017313842A patent/AU2017313842A1/en not_active Abandoned
- 2017-08-18 JP JP2019530368A patent/JP2019524889A/ja active Pending
- 2017-08-18 CA CA3033971A patent/CA3033971A1/en active Pending
- 2017-08-18 SG SG11201901328VA patent/SG11201901328VA/en unknown
- 2017-08-18 WO PCT/US2017/047584 patent/WO2018035449A1/en not_active Ceased
- 2017-08-18 KR KR1020197007605A patent/KR20190065252A/ko not_active Ceased
- 2017-08-18 EA EA201990513A patent/EA201990513A1/ru unknown
- 2017-08-18 BR BR112019003133-2A patent/BR112019003133A2/pt not_active IP Right Cessation
- 2017-08-18 EP EP17842205.1A patent/EP3500269A4/en not_active Withdrawn
- 2017-08-18 US US16/326,070 patent/US20190167660A1/en not_active Abandoned
- 2017-08-18 CN CN201780063392.8A patent/CN109843292A/zh active Pending
-
2022
- 2022-06-03 JP JP2022090843A patent/JP2022116294A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240299381A1 (en) | Methods of administering elagolix | |
| RU2018110647A (ru) | Арильные, гетероарильные и гетероциклические соединения для лечения заболеваний | |
| JP2014139220A5 (cg-RX-API-DMAC7.html) | ||
| MX2011007854A (es) | Metodos para tratar infartos agudos al miocardio y trastornos relacionados. | |
| Jabbour et al. | Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions | |
| MX2015017307A (es) | Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington. | |
| JP2015517493A5 (cg-RX-API-DMAC7.html) | ||
| EA201490163A1 (ru) | Ингибиторы кинуренин-3-монооксигеназы, фармацевтические композиции и способы их применения | |
| JP2015505564A5 (cg-RX-API-DMAC7.html) | ||
| ZA202000028B (en) | Use of vibegron to treat overactive bladder | |
| MX2021009539A (es) | Derivado del profarmaco 6-oxo-1,6-dihidropiridazina, metodo de preparacion del mismo y aplicacion del mismo en medicina. | |
| JP2019507786A5 (cg-RX-API-DMAC7.html) | ||
| JP2019524889A5 (cg-RX-API-DMAC7.html) | ||
| JP2016505050A5 (cg-RX-API-DMAC7.html) | ||
| RU2020120156A (ru) | Лечение приливов и потери костной ткани, вызванных андрогенной депривационной терапией с применением цис-кломифена | |
| JP2018536638A5 (cg-RX-API-DMAC7.html) | ||
| EA202193190A1 (ru) | Композиция, включающая придопидин и его аналог, для лечения болезни гентингтона и ее симптомов | |
| JP2019529569A5 (cg-RX-API-DMAC7.html) | ||
| EA201992826A1 (ru) | 15бета-[3-пропанамидо]-замещенные эстра-1,3,5(10)-триен-17-оны и их 17-оксимы для применения в ингибировании 17бета-гидроксистероиддегидрогеназ | |
| HRP20211661T1 (hr) | Igmezin, namijenjen upotrebi u liječenju alzheimerove bolesti | |
| JP2022116294A (ja) | 骨疾患の治療のためのＰＰＡＲγアゴニスト | |
| JP2019535830A5 (cg-RX-API-DMAC7.html) | ||
| JP2020505448A5 (cg-RX-API-DMAC7.html) | ||
| GEAP202516774A (en) | Compactable oral formulations of ibutamoren | |
| RU2013126798A (ru) | Комбинированная терапия дексаметазоном |